Pyrimidines maintain mitochondrial pyruvate oxidation to support de novo lipogenesis
Science · 29.03.2024 · 383 (6690) · 1484-1492
DOI: 10.1126/science.adh2771 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 29.03.2024. Verfasst von Umakant Sahu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. Hauptthemen laut MEDLINE: Lipogenesis, Pyrimidines, Pyruvates, Citric Acid Cycle. Die Arbeit wurde bisher 86-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
Cellular purines, particularly adenosine 5′-triphosphate (ATP), fuel many metabolic reactions, but less is known about the direct effects of pyrimidines on cellular metabolism. We found that pyrimidines, but not purines, maintain pyruvate oxidation and the tricarboxylic citric acid (TCA) cycle by regulating pyruvate dehydrogenase (PDH) activity. PDH activity requires sufficient substrates and cofactors, including thiamine pyrophosphate (TPP). Depletion of cellular pyrimidines decreased TPP synthesis, a reaction carried out by TPP kinase 1 (TPK1), which reportedly uses ATP to phosphorylate thiamine (vitamin B1). We found that uridine 5′-triphosphate (UTP) acts as the preferred substrate for TPK1, enabling cellular TPP synthesis, PDH activity, TCA-cycle activity, lipogenesis, and adipocyte differentiation. Thus, UTP is required for vitamin B1 utilization to maintain pyruvate oxidation and lipogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA.
- Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
- BioRankings, St. Louis, MO 63108, USA.
- Mass Spectrometry Core, Beth Israel Deaconess Medical Center, Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
- Metabolomics Core Facility, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA.
ORCID-Profile: Umakant Sahu, Elodie Villa, Colleen R Reczek, Zibo Zhao, Michael D Torno, John M Asara, Peng Gao, Ali Shilatifard, Navdeep S Chandel, Issam Ben-Sahra
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- NIA NIH HHS
Zitieren
APA
Sahu, U., Villa, E., Reczek, C. R., Zhao, Z., O'Hara, B. P., Torno, M. D., Mishra, R., Shannon, W. D., Asara, J. M., Gao, P., Shilatifard, A., Chandel, N. S., & Ben-Sahra, I. (2024). Pyrimidines maintain mitochondrial pyruvate oxidation to support de novo lipogenesis. Science, 383(6690), 1484-1492. https://doi.org/10.1126/science.adh2771
Vancouver
Sahu U, Villa E, Reczek CR, Zhao Z, O'Hara BP, Torno MD, et al. Pyrimidines maintain mitochondrial pyruvate oxidation to support de novo lipogenesis. Science. 2024;383(6690):1484-1492. doi:10.1126/science.adh2771
BibTeX
@article{Sahu2024,
author = {Sahu, Umakant and Villa, Elodie and Reczek, Colleen R and Zhao, Zibo and O'Hara, Brendan P and Torno, Michael D and Mishra, Rohan and Shannon, William D and Asara, John M and Gao, Peng and Shilatifard, Ali and Chandel, Navdeep S and Ben-Sahra, Issam},
title = {Pyrimidines maintain mitochondrial pyruvate oxidation to support de novo lipogenesis},
journal = {Science},
year = {2024},
volume = {383},
number = {6690},
pages = {1484--1492},
doi = {10.1126/science.adh2771}
}
EUVIMED